Heide Ford
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homeodomain Proteins | 28 | 2023 | 465 | 7.590 |
Why?
| Protein Tyrosine Phosphatases | 16 | 2024 | 147 | 4.240 |
Why?
| Breast Neoplasms | 19 | 2020 | 1872 | 3.110 |
Why?
| Gene Expression Regulation, Neoplastic | 20 | 2023 | 1143 | 2.580 |
Why?
| Epithelial-Mesenchymal Transition | 9 | 2020 | 168 | 2.430 |
Why?
| Nuclear Proteins | 12 | 2023 | 595 | 2.200 |
Why?
| Intracellular Signaling Peptides and Proteins | 12 | 2023 | 389 | 2.150 |
Why?
| Neoplasm Metastasis | 13 | 2020 | 526 | 1.750 |
Why?
| Vascular Endothelial Growth Factor C | 3 | 2020 | 16 | 1.640 |
Why?
| Cell Line, Tumor | 27 | 2023 | 2749 | 1.590 |
Why?
| Neoplastic Stem Cells | 7 | 2021 | 330 | 1.590 |
Why?
| Transforming Growth Factor beta | 5 | 2012 | 447 | 1.550 |
Why?
| Neoplasms | 13 | 2020 | 2114 | 1.550 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 5 | 2017 | 40 | 1.400 |
Why?
| Cell Transformation, Neoplastic | 5 | 2015 | 312 | 1.370 |
Why?
| Sarcoma, Ewing | 2 | 2023 | 62 | 1.220 |
Why?
| MicroRNAs | 4 | 2015 | 610 | 1.220 |
Why?
| Muscle Development | 2 | 2022 | 97 | 1.220 |
Why?
| Drug Resistance, Neoplasm | 8 | 2017 | 638 | 1.190 |
Why?
| DNA-Binding Proteins | 5 | 2018 | 1318 | 1.180 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 157 | 1.080 |
Why?
| Zebrafish Proteins | 2 | 2022 | 246 | 1.060 |
Why?
| Transcription Factors | 7 | 2022 | 1535 | 1.040 |
Why?
| Mammary Glands, Human | 4 | 2010 | 60 | 1.000 |
Why?
| Up-Regulation | 7 | 2018 | 824 | 0.920 |
Why?
| Cerebellar Neoplasms | 1 | 2023 | 131 | 0.810 |
Why?
| Medulloblastoma | 1 | 2023 | 172 | 0.800 |
Why?
| Rhabdomyosarcoma | 1 | 2022 | 52 | 0.770 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 26 | 0.760 |
Why?
| Neuropilin-2 | 1 | 2020 | 3 | 0.760 |
Why?
| Mammary Neoplasms, Experimental | 5 | 2012 | 64 | 0.740 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 178 | 0.730 |
Why?
| Animals | 39 | 2022 | 32158 | 0.730 |
Why?
| Cell Transdifferentiation | 2 | 2010 | 31 | 0.710 |
Why?
| Cadherins | 2 | 2014 | 175 | 0.700 |
Why?
| Mice, SCID | 8 | 2019 | 321 | 0.680 |
Why?
| Signal Transduction | 12 | 2020 | 4527 | 0.660 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 57 | 0.650 |
Why?
| Epithelial Cells | 5 | 2012 | 961 | 0.640 |
Why?
| Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 16 | 0.640 |
Why?
| RNA-Binding Protein EWS | 2 | 2023 | 16 | 0.640 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 60 | 0.630 |
Why?
| Neoplasm Proteins | 3 | 2018 | 388 | 0.630 |
Why?
| Mice | 24 | 2022 | 15085 | 0.620 |
Why?
| Protein Phosphatase 2 | 1 | 2018 | 30 | 0.620 |
Why?
| Transcriptional Activation | 2 | 2018 | 341 | 0.610 |
Why?
| Zinc Finger Protein GLI1 | 1 | 2017 | 21 | 0.590 |
Why?
| Mice, Inbred NOD | 6 | 2019 | 562 | 0.590 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 115 | 0.570 |
Why?
| Anion Transport Proteins | 1 | 2017 | 8 | 0.570 |
Why?
| Paracrine Communication | 1 | 2017 | 56 | 0.570 |
Why?
| Cell Proliferation | 11 | 2020 | 2196 | 0.560 |
Why?
| B7-H1 Antigen | 1 | 2018 | 138 | 0.560 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 54 | 0.550 |
Why?
| Down-Regulation | 2 | 2015 | 605 | 0.540 |
Why?
| Humans | 54 | 2023 | 115859 | 0.520 |
Why?
| Ribosomal Proteins | 1 | 2015 | 70 | 0.510 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 448 | 0.510 |
Why?
| Twist-Related Protein 1 | 1 | 2015 | 10 | 0.500 |
Why?
| Cell Cycle | 4 | 2013 | 546 | 0.500 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 116 | 0.500 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 537 | 0.490 |
Why?
| Mesoderm | 3 | 2009 | 138 | 0.480 |
Why?
| Epithelium | 3 | 2009 | 297 | 0.480 |
Why?
| Neoplasm Transplantation | 6 | 2014 | 235 | 0.460 |
Why?
| Branchio-Oto-Renal Syndrome | 2 | 2013 | 5 | 0.450 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 862 | 0.450 |
Why?
| Transcription, Genetic | 3 | 2014 | 1317 | 0.440 |
Why?
| Molecular Targeted Therapy | 2 | 2015 | 348 | 0.440 |
Why?
| Lung Neoplasms | 3 | 2019 | 2206 | 0.430 |
Why?
| Female | 26 | 2021 | 60070 | 0.430 |
Why?
| Superoxide Dismutase | 1 | 2014 | 332 | 0.420 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 796 | 0.420 |
Why?
| Cell Differentiation | 7 | 2022 | 1709 | 0.420 |
Why?
| Lymphangiogenesis | 1 | 2012 | 24 | 0.410 |
Why?
| Genes, Tumor Suppressor | 1 | 2012 | 78 | 0.410 |
Why?
| Protein Binding | 7 | 2020 | 1918 | 0.400 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 157 | 0.390 |
Why?
| Antineoplastic Agents | 3 | 2020 | 1891 | 0.390 |
Why?
| Mice, Nude | 7 | 2017 | 639 | 0.380 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 53 | 0.360 |
Why?
| Genes, Homeobox | 3 | 2022 | 50 | 0.350 |
Why?
| Bone Neoplasms | 1 | 2012 | 194 | 0.350 |
Why?
| Mice, Inbred BALB C | 4 | 2019 | 1169 | 0.340 |
Why?
| Cyclin A | 3 | 2009 | 15 | 0.340 |
Why?
| Embryonic Development | 1 | 2010 | 115 | 0.340 |
Why?
| Cell Movement | 5 | 2020 | 867 | 0.310 |
Why?
| Genomic Instability | 1 | 2008 | 38 | 0.310 |
Why?
| Gene Regulatory Networks | 2 | 2023 | 234 | 0.300 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1360 | 0.290 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 703 | 0.290 |
Why?
| Ovarian Neoplasms | 2 | 2012 | 407 | 0.280 |
Why?
| Prognosis | 5 | 2019 | 3344 | 0.280 |
Why?
| Tyrosine | 2 | 2024 | 218 | 0.270 |
Why?
| Heterografts | 3 | 2017 | 119 | 0.270 |
Why?
| Retina | 1 | 2008 | 269 | 0.260 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 303 | 0.250 |
Why?
| Gene Amplification | 1 | 2005 | 96 | 0.250 |
Why?
| Zebrafish | 2 | 2022 | 412 | 0.240 |
Why?
| Rosaniline Dyes | 1 | 2024 | 10 | 0.230 |
Why?
| Protein Stability | 2 | 2018 | 162 | 0.230 |
Why?
| Integrins | 1 | 2023 | 79 | 0.210 |
Why?
| Models, Biological | 4 | 2017 | 1647 | 0.210 |
Why?
| Myogenin | 1 | 2022 | 13 | 0.200 |
Why?
| Disease Progression | 3 | 2015 | 2423 | 0.200 |
Why?
| MyoD Protein | 1 | 2022 | 27 | 0.200 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.200 |
Why?
| MCF-7 Cells | 2 | 2020 | 106 | 0.200 |
Why?
| Cell Survival | 2 | 2017 | 1024 | 0.190 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 445 | 0.190 |
Why?
| Transplantation, Heterologous | 3 | 2012 | 188 | 0.190 |
Why?
| Small Molecule Libraries | 2 | 2019 | 81 | 0.180 |
Why?
| Cell Dedifferentiation | 2 | 2010 | 28 | 0.180 |
Why?
| Apoptosis | 3 | 2019 | 2377 | 0.180 |
Why?
| Enzyme Inhibitors | 4 | 2021 | 758 | 0.180 |
Why?
| BRCA1 Protein | 1 | 2020 | 57 | 0.180 |
Why?
| Hedgehog Proteins | 1 | 2020 | 172 | 0.170 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 11 | 0.170 |
Why?
| Glioblastoma | 1 | 2021 | 251 | 0.160 |
Why?
| Gene Expression Profiling | 3 | 2012 | 1550 | 0.160 |
Why?
| Antigens, CD | 2 | 2014 | 443 | 0.160 |
Why?
| Mutation | 1 | 2009 | 3371 | 0.160 |
Why?
| Cyclin A1 | 3 | 2009 | 4 | 0.160 |
Why?
| Tumor Cells, Cultured | 2 | 2019 | 850 | 0.160 |
Why?
| HEK293 Cells | 2 | 2018 | 603 | 0.150 |
Why?
| RNA, Small Interfering | 2 | 2017 | 545 | 0.150 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 816 | 0.150 |
Why?
| Cell Growth Processes | 2 | 2008 | 52 | 0.150 |
Why?
| Veratrum Alkaloids | 1 | 2017 | 17 | 0.150 |
Why?
| Maxilla | 1 | 2017 | 29 | 0.150 |
Why?
| Proteolysis | 2 | 2017 | 145 | 0.140 |
Why?
| Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| Promoter Regions, Genetic | 3 | 2010 | 1130 | 0.140 |
Why?
| Cellular Reprogramming | 1 | 2017 | 84 | 0.130 |
Why?
| Clone Cells | 1 | 2016 | 247 | 0.130 |
Why?
| Protein Structure, Tertiary | 2 | 2009 | 804 | 0.130 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 511 | 0.130 |
Why?
| Multigene Family | 2 | 2008 | 198 | 0.130 |
Why?
| Immunohistochemistry | 2 | 2018 | 1644 | 0.130 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 137 | 0.130 |
Why?
| Endothelin-1 | 1 | 2017 | 167 | 0.130 |
Why?
| Tumor Burden | 2 | 2017 | 261 | 0.130 |
Why?
| Trans-Activators | 2 | 2010 | 369 | 0.120 |
Why?
| Cell Nucleus | 2 | 2009 | 554 | 0.120 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.120 |
Why?
| Mass Spectrometry | 1 | 2018 | 643 | 0.120 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 113 | 0.120 |
Why?
| Claudins | 1 | 2014 | 24 | 0.120 |
Why?
| Survival Rate | 1 | 2019 | 1649 | 0.120 |
Why?
| Child | 2 | 2023 | 18537 | 0.120 |
Why?
| Tumor Microenvironment | 1 | 2017 | 424 | 0.120 |
Why?
| Autophagy | 1 | 2016 | 236 | 0.120 |
Why?
| Gene Expression | 3 | 2009 | 1442 | 0.120 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2015 | 81 | 0.120 |
Why?
| Pyrimidines | 1 | 2017 | 376 | 0.120 |
Why?
| Genes, MHC Class I | 2 | 2005 | 32 | 0.120 |
Why?
| Biomedical Research | 1 | 2020 | 589 | 0.120 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2365 | 0.120 |
Why?
| Transfection | 3 | 2017 | 868 | 0.120 |
Why?
| Pyridines | 1 | 2017 | 425 | 0.110 |
Why?
| Phosphorylation | 1 | 2018 | 1562 | 0.110 |
Why?
| Aldehyde Dehydrogenase | 1 | 2014 | 129 | 0.110 |
Why?
| Brain Neoplasms | 1 | 2021 | 979 | 0.110 |
Why?
| G1 Phase | 1 | 2013 | 68 | 0.110 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2013 | 37 | 0.110 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2018 | 688 | 0.110 |
Why?
| Disease-Free Survival | 1 | 2014 | 621 | 0.110 |
Why?
| Cluster Analysis | 2 | 2012 | 466 | 0.110 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1045 | 0.100 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2017 | 136 | 0.100 |
Why?
| Antibodies, Neoplasm | 1 | 2012 | 29 | 0.100 |
Why?
| Reactive Oxygen Species | 1 | 2014 | 550 | 0.100 |
Why?
| Etoposide | 1 | 2012 | 149 | 0.100 |
Why?
| Energy Metabolism | 1 | 2017 | 713 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 754 | 0.100 |
Why?
| Repressor Proteins | 1 | 2014 | 369 | 0.100 |
Why?
| Amino Acid Sequence | 4 | 2014 | 2003 | 0.100 |
Why?
| DNA Damage | 2 | 2017 | 356 | 0.100 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 168 | 0.100 |
Why?
| Lymphatic Metastasis | 1 | 2012 | 276 | 0.100 |
Why?
| Cell Death | 2 | 2021 | 325 | 0.090 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 40 | 0.090 |
Why?
| Doxorubicin | 1 | 2012 | 290 | 0.090 |
Why?
| Antioxidants | 1 | 2014 | 534 | 0.090 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 533 | 0.090 |
Why?
| Antigens, Differentiation | 1 | 2010 | 79 | 0.090 |
Why?
| Pancreatic Neoplasms | 1 | 2017 | 721 | 0.090 |
Why?
| Follow-Up Studies | 1 | 2019 | 4443 | 0.090 |
Why?
| Lymphoma | 1 | 2011 | 177 | 0.090 |
Why?
| Metaplasia | 1 | 2009 | 54 | 0.090 |
Why?
| Smad3 Protein | 1 | 2009 | 41 | 0.090 |
Why?
| Salivary Proteins and Peptides | 1 | 2009 | 10 | 0.080 |
Why?
| Submandibular Gland | 1 | 2009 | 15 | 0.080 |
Why?
| Mutant Proteins | 1 | 2009 | 96 | 0.080 |
Why?
| Lactation | 1 | 2010 | 149 | 0.080 |
Why?
| Oxidative Stress | 1 | 2014 | 1095 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2009 | 267 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2009 | 327 | 0.080 |
Why?
| Eye Neoplasms | 1 | 2008 | 15 | 0.080 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 138 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 944 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 935 | 0.070 |
Why?
| Protein Transport | 1 | 2009 | 400 | 0.070 |
Why?
| Allosteric Regulation | 2 | 2019 | 84 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2021 | 511 | 0.070 |
Why?
| Ubiquitin | 1 | 2006 | 65 | 0.070 |
Why?
| Amino Acid Motifs | 1 | 2006 | 198 | 0.070 |
Why?
| Blotting, Western | 2 | 2011 | 1153 | 0.070 |
Why?
| Ovary | 1 | 2007 | 190 | 0.060 |
Why?
| Crystallography, X-Ray | 2 | 2019 | 409 | 0.060 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2005 | 18 | 0.060 |
Why?
| Antigens, CD1 | 1 | 2005 | 57 | 0.060 |
Why?
| Chickens | 1 | 2005 | 183 | 0.060 |
Why?
| Models, Molecular | 3 | 2019 | 1391 | 0.060 |
Why?
| Precipitin Tests | 1 | 2004 | 90 | 0.060 |
Why?
| Cell Line | 2 | 2014 | 2657 | 0.060 |
Why?
| Phylogeny | 2 | 2005 | 806 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2009 | 1971 | 0.060 |
Why?
| RNA, Messenger | 2 | 2012 | 2581 | 0.060 |
Why?
| Cyclin D1 | 1 | 2003 | 61 | 0.060 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 32 | 0.060 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 4779 | 0.060 |
Why?
| Dogfish | 1 | 2003 | 4 | 0.060 |
Why?
| Fibroblasts | 1 | 2008 | 838 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2012 | 3587 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1871 | 0.050 |
Why?
| DNA, Complementary | 1 | 2003 | 262 | 0.050 |
Why?
| DNA | 1 | 2009 | 1357 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 760 | 0.050 |
Why?
| Neovascularization, Pathologic | 1 | 2004 | 283 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2005 | 442 | 0.050 |
Why?
| Developmental Biology | 1 | 2020 | 18 | 0.040 |
Why?
| Neural Stem Cells | 1 | 2021 | 114 | 0.040 |
Why?
| Cell Plasticity | 1 | 2020 | 24 | 0.040 |
Why?
| Fibrosis | 1 | 2022 | 458 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 2014 | 2796 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 2 | 2014 | 353 | 0.040 |
Why?
| Terminology as Topic | 1 | 2020 | 186 | 0.040 |
Why?
| Peptides | 1 | 2024 | 864 | 0.040 |
Why?
| Treatment Outcome | 1 | 2012 | 9163 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 208 | 0.040 |
Why?
| Pregnancy | 1 | 2010 | 5555 | 0.040 |
Why?
| Consensus | 1 | 2020 | 531 | 0.040 |
Why?
| Sp7 Transcription Factor | 1 | 2017 | 7 | 0.040 |
Why?
| Zygoma | 1 | 2017 | 11 | 0.040 |
Why?
| Serrate-Jagged Proteins | 1 | 2017 | 27 | 0.040 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| Branchial Region | 1 | 2017 | 33 | 0.040 |
Why?
| Receptor, Endothelin A | 1 | 2017 | 59 | 0.040 |
Why?
| Craniofacial Abnormalities | 1 | 2017 | 59 | 0.040 |
Why?
| Diphtheria Toxin | 1 | 2016 | 51 | 0.030 |
Why?
| Autophagy-Related Proteins | 1 | 2016 | 39 | 0.030 |
Why?
| Receptors, Notch | 1 | 2017 | 85 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2017 | 215 | 0.030 |
Why?
| Body Patterning | 1 | 2017 | 126 | 0.030 |
Why?
| Integrases | 1 | 2017 | 117 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2016 | 161 | 0.030 |
Why?
| Neural Crest | 1 | 2017 | 117 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 192 | 0.030 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 390 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 275 | 0.030 |
Why?
| Cell Adhesion | 1 | 2017 | 433 | 0.030 |
Why?
| Calcium Signaling | 1 | 2017 | 211 | 0.030 |
Why?
| RNA Interference | 1 | 2017 | 438 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2016 | 377 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 75 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 62 | 0.030 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 102 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 617 | 0.030 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 23 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 145 | 0.030 |
Why?
| Adult | 1 | 2015 | 30814 | 0.030 |
Why?
| Amino Acids | 1 | 2017 | 456 | 0.030 |
Why?
| DNA Primers | 2 | 2005 | 514 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6182 | 0.030 |
Why?
| Phenylhydrazines | 1 | 2012 | 3 | 0.030 |
Why?
| Protein Phosphatase 2C | 1 | 2012 | 14 | 0.030 |
Why?
| Miniaturization | 1 | 2012 | 24 | 0.030 |
Why?
| Fluoresceins | 1 | 2012 | 46 | 0.030 |
Why?
| Enzyme Assays | 1 | 2012 | 22 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 238 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 44 | 0.030 |
Why?
| Spleen | 2 | 2005 | 492 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2012 | 63 | 0.030 |
Why?
| Spectrometry, Fluorescence | 1 | 2012 | 158 | 0.020 |
Why?
| Antibody Specificity | 1 | 2012 | 180 | 0.020 |
Why?
| Sequence Analysis, DNA | 2 | 2005 | 737 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2011 | 47 | 0.020 |
Why?
| Mutation, Missense | 1 | 2013 | 296 | 0.020 |
Why?
| Fas Ligand Protein | 1 | 2011 | 58 | 0.020 |
Why?
| High-Throughput Screening Assays | 1 | 2012 | 124 | 0.020 |
Why?
| Male | 2 | 2021 | 56103 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 316 | 0.020 |
Why?
| Brain | 1 | 2021 | 2372 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1568 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 324 | 0.020 |
Why?
| Organ Size | 1 | 2009 | 434 | 0.020 |
Why?
| Bursa of Fabricius | 1 | 2005 | 2 | 0.020 |
Why?
| Blotting, Southern | 1 | 2005 | 66 | 0.020 |
Why?
| Sequence Homology | 1 | 2005 | 40 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 194 | 0.020 |
Why?
| Conserved Sequence | 1 | 2005 | 220 | 0.020 |
Why?
| Sequence Alignment | 1 | 2005 | 328 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2005 | 505 | 0.010 |
Why?
| Mice, Knockout | 1 | 2009 | 2608 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 211 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2003 | 523 | 0.010 |
Why?
| Base Sequence | 1 | 2005 | 2121 | 0.010 |
Why?
| Biological Evolution | 1 | 2003 | 418 | 0.010 |
Why?
| Genetic Variation | 1 | 2003 | 893 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2005 | 2004 | 0.010 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|